Showing results (341-350 of 384) with videos related to

Sort By:
Pageof 39
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
JAMA|November 22, 2007
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancerLionel L Bañez, Robert J Hamilton, Alan W Partin, et al.
The Prostate|May 21, 2008
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populationsJielin Sun, Bao-Li Chang, Sarah D Isaacs, et al.
The Prostate|March 26, 2008
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African AmericansJielin Sun, Lina Purcell, Zhengrong Gao, et al.
BJU International|October 16, 2016
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancerStacy Loeb, Sanghyuk S Shin, Dennis L Broyles, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
European Urology|May 24, 2020
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical TrialHiten D Patel, Farzana A Faisal, Bruce J Trock, et al.
The Journal of Urology|January 18, 2011
Predicting 15-year prostate cancer specific mortality after radical prostatectomyScott E Eggener, Peter T Scardino, Patrick C Walsh, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosisSamir S Taneja, Elias I Hsu, Carol D Cheli, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancerDiane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Pageof 39